Non-coding RNA transcripts longer than 200 nucleotides that lack productive open reading frames yet fold into modular secondary and tertiary domains to orchestrate chromatin architecture, transcriptional control, and nuclear subcompartment assembly. Exemplified by XIST (which coats and silences an entire X chromosome for mammalian dosage compensation) and HOTAIR (which scaffolds histone-modifying enzymes across chromosomes), lncRNAs outnumber protein-coding genes in the human genome.
Class
Long regulatory and structural non-coding RNA (>200 nucleotides)
Typical Length
200 to >100,000 nucleotides (human XIST is ~17,000–19,000 nt)
Subcellular Location
Predominantly nucleus (chromatin, speckles, paraspeckles); subset in cytoplasm
Epigenetic chromatin scaffolding, enhancer transcription, nuclear body assembly, and miRNA sequestration
Clinical / Biotech Use
Oncology diagnostic biomarkers (PCA3 in prostate cancer) and ASO-mediated gene unsilencing (UBE3A-ATS in Angelman syndrome)
Structure & Biogenesis
Transcribed by RNA polymerase II from intergenic regions (lincRNAs), bidirectional promoters, enhancers (eRNAs), or the antisense strand of protein-coding loci, and classified by an operational threshold of at least 200 nucleotides that separates them from miRNAs, siRNAs, snRNAs, and snoRNAs.
Like messenger RNAs, most lncRNAs receive a 5' 7-methylguanosine cap, undergo spliceosomal intron removal (albeit with fewer exons and lower splicing efficiency than coding transcripts), and acquire a 3' poly(A) tail, though a notable subset (such as MALAT1 and NEAT1_2) is stabilized at the 3' end by a triple-helical RNA element cleaved by RNase P (ribozyme).
Mechanism of Action
As synthesized by John Rinn and Howard Chang (2012) and Johnny Kung, David Colognori, and Jeannie Lee (2013), lncRNAs operate through four principal molecular archetypes: as signals transcribed in a cell-type- or stimulus-specific window; as decoys that titrate transcription factors or microRNAs away from their targets; as guides that recruit chromatin-modifying complexes in cis (to neighboring loci on the same chromosome, as XIST spreads across the inactive X) or in trans (to distant chromosomes); and as scaffolds that tether multiple protein complexes into a single ribonucleoprotein assembly.
Biological & Regulatory Roles
Dosage compensation: XIST is expressed exclusively from the future inactive X chromosome in female XX somatic cells, coating the chromosome in cis to trigger Histone H3 lysine-27 trimethylation (H3K27me3), nuclear lamin tethering, and faculties of heterochromatic silencing.
Genomic imprinting and developmental patterning: Antisense lncRNAs such as KCNQ1OT1, AIRN, ANRIL (which silences p16INK4a at the CDKN2A locus), and HOTAIR (transcribed from the HOXC cluster to repress HOXD genes) establish allele- and segment-specific epigenetic states.
Nuclear subcompartments: NEAT1 serves as the essential architectural scaffold for nuclear paraspeckles, while MALAT1 localizes to nuclear speckles adjacent to spliceosomal snRNPs.
Interactions & Complexes
Cytoplasmic lncRNAs interact with the ribosome, ribonucleases, and Argonaute complexes (such as let-7 and miR-21 miRISCs) to modulate mRNA stability and translation.
Stress-induced lncRNAs such as lincRNA-p21 are directly activated by p53 alongside p21 within the p53 DNA-damage response cascade.
Therapeutic & Biotechnology Applications
Urine quantification of the prostate-specific lncRNA PCA3 is an established clinical diagnostic assay for prostate cancer, while nuclear-acting antisense oligonucleotides (gapmers) are in clinical trials to degrade the paternal UBE3A-ATS lncRNA transcript and unsilence the paternal UBE3A gene in Angelman syndrome.